PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2026-02-24 (8)

Date Title Company
24-Feb-2026 Vir Biotechnology Reports Positive Updated Phase 1 Results for PSMA-targeting, PRO-XTEN® Dual-masked T-Cell Engager VIR-5500 in Patients with Metastatic Prostate Cancer Businesswire